secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRAIL, Inc. (GRAL)
CIK:        0001699031
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001699031-25-000189
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRAIL Q3 revenue $36.2M (+26% YoY); U.S. Galleri revenue $32.6M (+28%)
----------------------------------------------------------------------

- Net loss $89.0M, improving 29% YoY; adjusted EBITDA $(71.7)M.
- Galleri tests sold >45,000, up 39% YoY; PMA submission to FDA expected Q1 2026.
- Cash $547.1M at Sep 30; pro forma >$850M after private placement.
- Non-GAAP adjusted gross profit $20.0M (+69% YoY); gross loss $13.7M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699031/000169903125000189/0001699031-25-000189-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699031/000169903125000189/gral-20251112.htm
  HTML page:      https://secwatch.observer/filing/0001699031-25-000189

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer